Diploid is a Leuven-based genomics start-up that aims to revolutionize healthcare by bringing genome diagnostics into daily clinical practice. Peter Schols, CEO of Diploid, founded the company in 2014 out of his passion for both software development and genetics.
Dr. Rita Chen is an Associate Research Fellow at the Institute of Biological Chemistry (IBC) and is also a TIGP-CBMB faculty member. Dr. Chen was awarded her Ph.D. degree from the Department of Biochemistry at the prestigious University of Cambridge in 1998.
Financial technology, or most commonly known as FinTech, is a business made up of companies that adopt latest technology and innovation with existing resources in order to contest in the marketplace of traditional financial establishments and mediators in the delivery of financial services.
Kevin Tsai recently graduated from the Ph.D. program in Bioinformatics at Academia Sinica, Taiwan. Prior to graduating, he did contract work with McKinsey & Co. and held positions at Gilead Sciences and Celera.